123 related articles for article (PubMed ID: 37517600)
1. Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation Therapy.
Tsui JMG; Kehayias CE; Leeman JE; Nguyen PL; Peng L; Yang DD; Moningi S; Martin N; Orio PF; D'Amico AV; Bredfeldt JS; Lee LK; Guthier CV; King MT
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):74-84. PubMed ID: 37517600
[TBL] [Abstract][Full Text] [Related]
2. Focal dose escalation for prostate cancer using
Zamboglou C; Thomann B; Koubar K; Bronsert P; Krauss T; Rischke HC; Sachpazidis I; Drendel V; Salman N; Reichel K; Jilg CA; Werner M; Meyer PT; Bock M; Baltas D; Grosu AL
Radiat Oncol; 2018 May; 13(1):81. PubMed ID: 29716617
[TBL] [Abstract][Full Text] [Related]
3. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938
[TBL] [Abstract][Full Text] [Related]
4. [
Bettermann AS; Zamboglou C; Kiefer S; Jilg CA; Spohn S; Kranz-Rudolph J; Fassbender TF; Bronsert P; Nicolay NH; Gratzke C; Bock M; Ruf J; Benndorf M; Grosu AL
Radiother Oncol; 2019 Dec; 141():214-219. PubMed ID: 31431366
[TBL] [Abstract][Full Text] [Related]
5. 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.
Rischke HC; Nestle U; Fechter T; Doll C; Volegova-Neher N; Henne K; Scholber J; Knippen S; Kirste S; Grosu AL; Jilg CA
Radiat Oncol; 2013 Jul; 8():183. PubMed ID: 23875672
[TBL] [Abstract][Full Text] [Related]
6. Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.
Gibson E; Bauman GS; Romagnoli C; Cool DW; Bastian-Jordan M; Kassam Z; Gaed M; Moussa M; Gómez JA; Pautler SE; Chin JL; Crukley C; Haider MA; Fenster A; Ward AD
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):188-96. PubMed ID: 27375167
[TBL] [Abstract][Full Text] [Related]
7. Comparison of
Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and Initial Dosimetric Findings for a Randomized Trial Using Dose-Painted Multiparametric Magnetic Resonance Imaging-Defined Targets in Prostate Cancer.
Bossart EL; Stoyanova R; Sandler K; Studenski M; Orman A; Abramowitz M; Pollack A
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):827-34. PubMed ID: 27020109
[TBL] [Abstract][Full Text] [Related]
9. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.
Ciabatti S; Ntreta M; Buwenge M; Gaudiano C; Sessagesimi E; Romani F; Angelini AL; Cammelli S; Macchia G; Deodato F; Zamagni A; Golfieri R; Morganti AG; Cilla S
Med Dosim; 2019 Winter; 44(4):356-364. PubMed ID: 30955990
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition.
Sachpazidis I; Mavroidis P; Zamboglou C; Klein CM; Grosu AL; Baltas D
Radiat Oncol; 2020 Oct; 15(1):242. PubMed ID: 33081804
[TBL] [Abstract][Full Text] [Related]
11. Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI-A Correlation Study With Whole Mount Histopathological Information as Reference.
Kramer M; Spohn SKB; Kiefer S; Ceci L; Sigle A; Oerther B; Schultze-Seemann W; Gratzke C; Bock M; Bamberg F; Grosu AL; Benndorf M; Zamboglou C
Front Oncol; 2020; 10():596756. PubMed ID: 33330088
[TBL] [Abstract][Full Text] [Related]
12. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
[TBL] [Abstract][Full Text] [Related]
13. Boosting imaging defined dominant prostatic tumors: a systematic review.
Bauman G; Haider M; Van der Heide UA; Ménard C
Radiother Oncol; 2013 Jun; 107(3):274-81. PubMed ID: 23791306
[TBL] [Abstract][Full Text] [Related]
14. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
van Lin EN; Fütterer JJ; Heijmink SW; van der Vight LP; Hoffmann AL; van Kollenburg P; Huisman HJ; Scheenen TW; Witjes JA; Leer JW; Barentsz JO; Visser AG
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):291-303. PubMed ID: 16618584
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI.
Yilmaz EC; Harmon SA; Belue MJ; Merriman KM; Phelps TE; Lin Y; Garcia C; Hazen L; Patel KR; Merino MJ; Wood BJ; Choyke PL; Pinto PA; Citrin DE; Turkbey B
Eur J Radiol; 2023 Nov; 168():111095. PubMed ID: 37717420
[TBL] [Abstract][Full Text] [Related]
16. Intraindividual comparison between
Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the different 3D CT scanning modes on the GTV delineation for the solitary pulmonary lesion.
Shang DP; Liu CX; Yin Y
Radiat Oncol; 2014 Nov; 9():211. PubMed ID: 25391554
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of 4D MRI in the delineation of gross and internal tumor volumes in comparison with 4DCT.
Zhang J; Srivastava S; Wang C; Beckham T; Johnson C; Dutta P; Shepherd A; Mechalakos J; Hunt M; Wu A; Rimner A; Li G
J Appl Clin Med Phys; 2019 Sep; 20(9):51-60. PubMed ID: 31538719
[TBL] [Abstract][Full Text] [Related]
19. Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.
Murray LJ; Lilley J; Thompson CM; Cosgrove V; Mason J; Sykes J; Franks K; Sebag-Montefiore D; Henry AM
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):406-15. PubMed ID: 24685447
[TBL] [Abstract][Full Text] [Related]
20. Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.
Holzschuh JC; Mix M; Ruf J; Hölscher T; Kotzerke J; Vrachimis A; Doolan P; Ilhan H; Marinescu IM; Spohn SKB; Fechter T; Kuhn D; Bronsert P; Gratzke C; Grosu R; Kamran SC; Heidari P; Ng TSC; Könik A; Grosu AL; Zamboglou C
Radiother Oncol; 2023 Nov; 188():109774. PubMed ID: 37394103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
